BIOCHEMICAL ASSESSMENT OF PRO- AND ANTI-INFLAMMATORY CYTOKINES IN WOMEN WITH PREECLAMPSIA: A SINGLE CENTER STUDY
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
According to the International Society for the Study of Hypertension in Pregnancy (ISSHP), preeclampsia is defined as the presence of de novo hypertension after 20 weeks gestation accompanied by proteinuria and/or evidence of maternal acute kidney injury (AKI), liver dysfunction, neurological features, haemolysis or thrombocytopenia, or fetal growth restriction.1 Hypertension is defined as blood pressure of greater than or equal to 140/90 mmHg recorded on at least two separate occasions and at least 4 hours apart and proteinuria is defined as greater than or equal to 300 mg of protein in a 24-hour collection of urine.2 Although preeclampsia has long been recognized as an important global health burden responsible for more than 500,000 foetal and neonatal deaths and over 70,000 maternal deaths worldwide annually, its aetiology remains unknown.1 However, the role of cytokines which are low molecular weight polypeptides involved in regulation of immunity, inflammation and haemopoiesis have been identified.3 Cytokines are known to play a crucial role in ovulation, implantation, placentation, and parturition during pregnancy, serving as key mediators of several immunological cell signaling pathways.3,4 They help in placental invasion, proliferation, and angiogenesis. The inflammatory cytokines also affect the functioning of endothelial cells by increasing the vascular permeability and induces apoptosis of the trophoblastic cells and are central to the maternal inflammatory responses.3 The anti‐inflammatory cytokines are crucial for the functioning of T-helper cell 2 (Th2) and regulatory T-cells (Treg) for the successful progression of pregnancy.3 The balance of pro‐ and anti‐inflammatory cytokines play a crucial role in the development and functioning of the placenta, hence a disruption may contribute to the features seen in preeclampsia.5 Preeclampsia is a multi-organ system disorder of pregnancy responsible for a significant number of maternal morbidity and mortality. Globally, it is estimated that preeclampsia-related deaths account for 12% of maternal deaths annually.6 World Health Organization (WHO) estimates that preeclampsia and eclampsia affects as much as 2-10% of pregnancies globally, with developing countries accounting for the higher burden.7 In African countries such as South Africa, Egypt, Tanzania, and Ethiopia, the incidence of preeclampsia varies from 1.8% to 7.1%, while in Nigeria, it ranges between 2% to 16.7%.8 A hospital based study done in North-Central Nigeria, reported that preeclampsia complicates up to 8.8% of pregnancies.9 This is slightly higher than in the Southern part of the country were it complicates 5.6% of pregnancies and accounts for 77.9% of all cases of hypertensive disorders in pregnancy.10 Despite the significant health burden of preeclampsia, the problem is confounded by the continued mystery of the aetiology and the unpredictable nature of the disease.
Fields of Study & Subjects
Pregnancy and preeclampsia studies
Reproductive System and Pregnancy
Preterm Birth and Chorioamnionitis
Publication details
- Journal / source
- Cognizance Journal of Multidisciplinary Studies
- Volume
- 6
- Issue
- 3
- Pages
- 203–211
- Publication date
- 28 March 2026
- Language
- EN